Your browser doesn't support javascript.
loading
Consideration of breast cancer subtype in targeting the androgen receptor.
Venema, Clasina M; Bense, Rico D; Steenbruggen, Tessa G; Nienhuis, Hilde H; Qiu, Si-Qi; van Kruchten, Michel; Brown, Myles; Tamimi, Rulla M; Hospers, Geke A P; Schröder, Carolina P; Fehrmann, Rudolf S N; de Vries, Elisabeth G E.
Afiliação
  • Venema CM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Bense RD; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Steenbruggen TG; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Nienhuis HH; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Qiu SQ; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, China.
  • van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Tamimi RM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Fehrmann RSN; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.
Pharmacol Ther ; 200: 135-147, 2019 08.
Article em En | MEDLINE | ID: mdl-31077689
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Pharmacol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Pharmacol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda